Literature DB >> 9040740

Indictment of the microglia as the villain in multiple sclerosis.

S Sriram1, M Rodriguez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040740     DOI: 10.1212/wnl.48.2.464

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  28 in total

1.  Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells.

Authors:  M J Carson; C R Reilly; J G Sutcliffe; D Lo
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

2.  Acute multiple sclerosis characterized by extensive mononuclear phagocyte infiltration.

Authors:  D C Shields; N G Avgeropoulos; N L Banik; W R Tyor
Journal:  Neurochem Res       Date:  2000-11       Impact factor: 3.996

Review 3.  Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis.

Authors:  E M Frohman; N L Monson; A E Lovett-Racke; M K Racke
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

4.  Decreased microglial activation in MS patients treated with glatiramer acetate.

Authors:  John N Ratchford; Christopher J Endres; Dima A Hammoud; Martin G Pomper; Navid Shiee; John McGready; Dzung L Pham; Peter A Calabresi
Journal:  J Neurol       Date:  2011-12-09       Impact factor: 4.849

Review 5.  Role of microglia in multiple sclerosis.

Authors:  Xinqing Deng; Subramaniam Sriram
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

6.  Microglial stability and repopulation in the retina.

Authors:  T A Albini; R C Wang; B Reiser; E Zamir; G S Wu; N A Rao
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

Review 7.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

Authors:  Dustin J Donnelly; Phillip G Popovich
Journal:  Exp Neurol       Date:  2007-06-30       Impact factor: 5.330

8.  Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders.

Authors:  Thomas Stahnke; Christine Stadelmann; Anne Netzler; Wolfgang Brück; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

9.  Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease.

Authors:  Anne R Gocke; Rehana Z Hussain; Yuhong Yang; Haiyan Peng; Jeffrey Weiner; Li-Hong Ben; Paul D Drew; Olaf Stuve; Amy E Lovett-Racke; Michael K Racke
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 10.  Phagocytosis of myelin in demyelinative disease: a review.

Authors:  M E Smith
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.